Novel Coronavirus (SARS-CoV-2/COVID-19)
The Department of Health and Human Services announced it has expanded the providers eligible for its Public Health and Social Services Emergency Fund “General Distribution.”
COVID-19 has prompted many changes in the way hospitals manage and care for their patients. As hospitals across the nation deal with the ebb and flow of COVID-19 patients and shortages of ICU beds, North Carolina’s Atrium Health has found a promising solution to increasing their inpatient capacity…
This AHA Special Bulletin provides details on the Department of Health and Human Services’ announcement that it has expanded the providers eligible for its Public Health and Social Services Emergency Fund “General Distribution.”
Thank you for your continued heroic work to care for your communities as our nation battles the COVID-19 pandemic. As you likely know, the Department of Health and Human Services (HHS) has requested that all hospitals report certain data on bed capacity, utilization, personal protective equipment (…
The Delaware health system led webinars on COVID-19 safety for barbershops and salons in underserved communities, donated sanitation kits and shared educational materials.
Caregivers at INTEGRIS Health, based in Oklahoma City, are featured in a social media campaign about wearing face masks to slow the spread of COVID-19.
On June 4, Lincoln County Public Health (LCPH) recorded an outbreak of confirmed COVID-19 cases in Newport, Oregon, located about 85 miles southwest of Salem, Oregon. Five of these cases were connected to Pacific Seafood and they immediately began working with LCPH to get their employees tested.
Houston’s Kindred Healthcare and TIRR Memorial Hermann are among the many post-acute care providers that have incurred increased costs to prepare for and treat COVID-19-positive patients and complex post-COVID-19 patients.
The Food and Drug Administration authorized the emergency use of George Washington University Public Health Laboratory’s GWU SARS-CoV-2 RT-PCR Test.
Researchers have launched two clinical trials to test whether monoclonal (laboratory-made) antibodies can safely prevent SARS-CoV-2 infection or symptoms in healthy adults, the National Institutes of Health announced.